Simplex Trading, LLC Atreca, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$0.06 - $0.36 $5 - $35	-99 Reduced 99.0%	1 $0
Q4 2023 Feb 02, 2024	BUY	$0.13 - $0.38 $13 - $38	100 New	100 $0
Q4 2022 Feb 02, 2023	SELL	$0.78 - $1.68 $262 - $566	-337 Reduced 6.5%	4,846 $3,000
Q3 2022 Nov 04, 2022	SELL	$1.59 - $2.74 $1,491 - $2,570	-938 Reduced 15.32%	5,183 $8,000
Q2 2022 Aug 03, 2022	BUY	$1.56 - $3.25 $397 - $828	255 Added 4.35%	6,121 $10,000
Q1 2022 May 02, 2022	BUY	$1.61 - $5.2 $3,488 - $11,268	2,167 Added 58.58%	5,866 $18,000
Q4 2021 Feb 23, 2022	SELL	$2.87 - $6.29 $34,609 - $75,851	-12,059 Reduced 76.53%	3,699 $11,000
Q2 2021 Aug 12, 2021	BUY	$7.82 - $13.8 $123,227 - $217,460	15,758 New	15,758 $134,000
Q1 2021 Apr 26, 2021	SELL	$13.0 - $19.34 $7,072 - $10,520	-544 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$13.03 - $17.09 $7,088 - $9,296	544 New	544 $8,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.